MIDATECH LTD.
22Patents
21Active
22Granted
51Portfolio score
Filing activity: Oct 16, 2001 → Jun 11, 2020 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8895023B2 | Nanoparticles for providing immune responses against infectious agents | Emerging Cross-Sectional Technologies | 25 | Active |
| US7364919B2 | Nanoparticles | Emerging Cross-Sectional Technologies | 8 | Expired |
| US8568781B2 | Peptide-carrying nanoparticles | Human Necessities | 4 | Active |
| US9079765B2 | Nanoparticles comprising antigens and adjuvants, and immunogenic structures | Emerging Cross-Sectional Technologies | 2 | Active |
| US8425915B2 | Nanoparticles for providing immune responses against infectious agents | Emerging Cross-Sectional Technologies | 2 | Active |
| US9034380B2 | Nanoparticles comprising antibacterial ligands | Emerging Cross-Sectional Technologies | 2 | Active |
| US10688125B2 | Nanoparticles and their use in cancer therapy | Human Necessities | 2 | Active |
| US9598479B2 | Nanoparticle-peptide compositions | Human Necessities | 2 | Active |
| US10300022B2 | Nanoparticle delivery compositions | Emerging Cross-Sectional Technologies | 1 | Active |
| US8974826B2 | Nanoparticle film delivery systems | Emerging Cross-Sectional Technologies | 1 | Active |
| US8557607B2 | Magnetic nanoparticles | Emerging Cross-Sectional Technologies | 1 | Active |
| US8790934B2 | Nanoparticles | Emerging Cross-Sectional Technologies | 0 | Active |
| US8080431B2 | Nanoparticles | Emerging Cross-Sectional Technologies | 0 | Active |
| US11235068B2 | Cyclodextrin-panobinostat adduct | Chemistry; Metallurgy | 0 | Active |
| US8790704B2 | Combination peptide-nanoparticles and delivery systems incorporating same | Emerging Cross-Sectional Technologies | 0 | Active |
| US11179344B2 | Nanoparticle-based liver-targeting therapy | Performing Operations; Transporting | 0 | Active |
| US9114082B2 | Nanoparticle peptide compositions | Chemistry; Metallurgy | 0 | Active |
| US9352026B2 | Nanoparticle-insulin and insulin analogue compositions | Performing Operations; Transporting | 0 | Active |
| US11179474B1 | Nanoparticle-based liver-targeting therapy and imaging | Human Necessities | 0 | Active |
| US9125583B2 | Detection of cancer with electrical impedance tomography | Emerging Cross-Sectional Technologies | 0 | Active |
| US9474687B2 | Combination peptide-nanoparticles and delivery systems incorporating same | Emerging Cross-Sectional Technologies | 0 | Active |
| US10722597B2 | Cyclodextrin-panobinostat adduct | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.